Table 4.
Antibody | Antigen | In situ staining | In vitro staining | ||||
---|---|---|---|---|---|---|---|
GVEC | GPEC | MC | Endo | GVEC | MC | ||
C19 | WT1 | + | − | − | − | + | ± |
G1 | Synaptopodin | + | − | − | + | + | − |
5A | Podocalyxin | + | − | − | + | − | − |
27A | O-acetylated ganglioside | + | − | − | − | − | − |
V9 | Vimentin | + | + | − | + | + | + |
D33 | Desmin | − | − | + | − | − | + |
OX7 | Thy 1.1 | − | − | + | − | − | + |
1A4 | Smooth muscle actin | − | − | + | − | + | + |
Anti-Factor VIII | Factor VIII | − | − | − | + | − | − |
IIH6 | α-dystroglycan | + | − | − | − | ± | + |
GVEC, glomerular visceral epithelial cell or podocyte; GPEC, glomerular parietal epithelial cell; MC, mesangial cell; Endo, endothelial cell.
+, positive staining; −, negative staining